NeuroSense Therapeutics Ltd. (NRSN)
NASDAQ: NRSN · Real-Time Price · USD
0.780
-0.029 (-3.57%)
Apr 29, 2026, 10:51 AM EDT - Market open
NeuroSense Therapeutics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2019 |
| Cash & Equivalents | 0.17 | 3.38 | 2.64 | 3.54 | 11.06 | Upgrade
|
| Short-Term Investments | - | - | - | 3.55 | - | Upgrade
|
| Cash & Short-Term Investments | 0.17 | 3.38 | 2.64 | 7.09 | 11.06 | Upgrade
|
| Cash Growth | -95.09% | 27.96% | -62.76% | -35.91% | 1482.69% | Upgrade
|
| Other Receivables | 0.03 | 0.16 | 0.17 | 0.13 | 0.18 | Upgrade
|
| Receivables | 0.03 | 0.16 | 0.17 | 0.13 | 0.18 | Upgrade
|
| Inventory | 0.45 | 0.74 | - | - | - | Upgrade
|
| Prepaid Expenses | 0.08 | 0.09 | 0.07 | 0.12 | 0.13 | Upgrade
|
| Other Current Assets | 0.05 | 0.04 | 0.04 | 0.04 | 0.04 | Upgrade
|
| Total Current Assets | 0.78 | 4.4 | 2.92 | 7.38 | 11.41 | Upgrade
|
| Property, Plant & Equipment | 0.23 | 0.15 | 0.25 | 0.31 | 0.02 | Upgrade
|
| Other Long-Term Assets | 0.02 | 0.02 | 0.02 | 0.02 | - | Upgrade
|
| Total Assets | 1.03 | 4.58 | 3.19 | 7.72 | 11.43 | Upgrade
|
| Accounts Payable | 0.8 | 1.16 | 1.46 | 0.5 | 0.04 | Upgrade
|
| Accrued Expenses | 1.62 | 0.76 | 1.93 | 1.16 | 0.56 | Upgrade
|
| Current Portion of Leases | 0.1 | 0.07 | 0.07 | 0.06 | - | Upgrade
|
| Total Current Liabilities | 2.52 | 1.99 | 3.46 | 1.73 | 0.6 | Upgrade
|
| Long-Term Leases | 0.07 | - | 0.07 | 0.15 | - | Upgrade
|
| Other Long-Term Liabilities | - | - | 1.41 | - | 1.83 | Upgrade
|
| Total Liabilities | 2.59 | 1.99 | 4.94 | 1.87 | 2.43 | Upgrade
|
| Additional Paid-In Capital | 46.23 | 39.24 | 24.36 | 21.86 | 17.45 | Upgrade
|
| Retained Earnings | -47.79 | -36.66 | -26.12 | -16.01 | -8.45 | Upgrade
|
| Shareholders' Equity | -1.56 | 2.58 | -1.76 | 5.84 | 9.01 | Upgrade
|
| Total Liabilities & Equity | 1.03 | 4.58 | 3.19 | 7.72 | 11.43 | Upgrade
|
| Total Debt | 0.17 | 0.07 | 0.14 | 0.21 | - | Upgrade
|
| Net Cash (Debt) | -0 | 3.31 | 2.5 | 6.88 | 11.06 | Upgrade
|
| Net Cash Growth | - | 32.31% | -63.69% | -37.82% | 1482.69% | Upgrade
|
| Net Cash Per Share | -0.00 | 0.18 | 0.18 | 0.60 | 1.77 | Upgrade
|
| Filing Date Shares Outstanding | 35.35 | 23.99 | 15.6 | 11.79 | 10.94 | Upgrade
|
| Total Common Shares Outstanding | 32.56 | 23.23 | 15.38 | 11.78 | 10.94 | Upgrade
|
| Working Capital | -1.74 | 2.41 | -0.54 | 5.66 | 10.82 | Upgrade
|
| Book Value Per Share | -0.05 | 0.11 | -0.11 | 0.50 | 0.82 | Upgrade
|
| Tangible Book Value | -1.56 | 2.58 | -1.76 | 5.84 | 9.01 | Upgrade
|
| Tangible Book Value Per Share | -0.05 | 0.11 | -0.11 | 0.50 | 0.82 | Upgrade
|
| Machinery | 0.13 | 0.12 | 0.12 | 0.09 | 0.02 | Upgrade
|
| Leasehold Improvements | 0 | 0 | 0 | 0 | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.